# Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption

> **NCT02338713** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 27 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Calcichew D3
- **DRUG:** Noncarbonated Water

## Key facts

- **NCT ID:** NCT02338713
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338713, "Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02338713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*